title: A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva).
authors.forename: Gemma
authors.initials: G
authors.lastname: Márquez
authors.forename: Enrique
authors.initials: E
authors.lastname: Herrera-Acosta
authors.forename: Isabel
authors.initials: I
authors.lastname: Vidal
authors.forename: Loida
authors.initials: L
authors.lastname: Galvany
authors.forename: Maribel
authors.initials: M
authors.lastname: Iglesias
authors.forename: Pablo
authors.initials: P
authors.lastname: Umbert
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000601:surgery; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D000069347:Erlotinib Hydrochloride; D005140:Eyelashes / Q000187:drug effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced* / Q000503:physiopathology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000601:surgery; D008875:Middle Aged; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment
chemical_list: D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors